2,020 research outputs found

    Open Synthesis: Open Science in Evidence Synthesis (second speaker)

    No full text
    Slides to the session "Open Synthesis: Open Science in Evidence Synthesis" by Dr David Moher. Further details of the workshop can be found here: https://evidencesynthesisireland.ie/opensynthesis. Dr David Moher is a senior scientist, clinical epidemiology program, Ottawa Hospital Research Institute, where he directs the centre for journalology (publication science) (http://www.ohri.ca/journalology/). Dr Moher is also an Associate Professor, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, where he holds a University Research Chair. Dr Moher holds an MSc in epidemiology and PhD in clinical epidemiology and biostatistics. Dr Moher has been involved in developing the science of how to optimally conduct and report systematic reviews for most of his professional career. Another part of his research has focused on how best to develop reporting guidelines. He spearheaded the development of the CONSORT statement and the PRISMA statement. He has been actively involved in the development of many other reporting guidelines and is part of the EQUATOR Network. Dr Moher leads an active program investigating predatory journals and publishers. More recently Dr. Moher led a program to develop core competencies for scientific journal editors. He is actively developing a program to investigate alternatives to current incentives and rewards in academic medicine. Dr Moher has been recognized several times as a Clarivate Analytics Highly Cited Researcher (Web of Science). The presentation was part of the Open Scholarship Week 2020. It can be viewed at https://www.youtube.com/watch?v=fANpI4xX-l

    Peer Review - A talk with Dr. David Moher

    No full text
    Dr. David Moher is a clinical epidemiologist, Clinical Epidemiology Program, Ottawa Hospital Research Institute, where he directs the Centre for Journalology. He is also an associate director of the International Congress on Peer Review and Scientific Publication, a METRICS affiliate, Stanford University, chairs the EQUATOR Network, and is a member of the REWARD Alliance executive. Dr. Moher spends his time trying help to improve publication science

    Research Reproducibility 2016: David Moher

    No full text
    Biomedical research can be reproduced when it is completely and transparently reported: can reporting guidelines help

    Four Proposals to Help Improve the Medical Research Literature.

    No full text
    David Moher and Douglas Altman outline four potential interventions that may improve the quality of peer-reviewed medical research publications

    Lessons from the COVID-19 pandemic and recent developments on the communication of clinical trials, publishing practices, and research integrity: in conversation with Dr. David Moher

    No full text
    BACKGROUND: The torrent of research during the coronavirus (COVID-19) pandemic has exposed the persistent challenges with reporting trials, open science practices, and scholarship in academia. These real-world examples provide unique learning opportunities for research methodologists and clinical epidemiologists-in-training. Dr. David Moher, a recognized expert on the science of research reporting and one of the founders of the Consolidated Standards of Reporting Trials (CONSORT) statement, was a guest speaker for the 2021 Hooker Distinguished Visiting Professor Lecture series at McMaster University and shared his insights about these issues. MAIN TEXT: This paper covers a discussion on the influence of reporting guidelines on trials and issues with the use of CONSORT as a measure of quality. Dr. Moher also addresses how the overwhelming body of COVID-19 research reflects the “publish or perish” paradigm in academia and why improvement in the reporting of trials requires policy initiatives from research institutions and funding agencies. We also discuss the rise of publication bias and other questionable reporting practices. To combat this, Dr. Moher believes open science and training initiatives led by institutions can foster research integrity, including the trustworthiness of researchers, institutions, and journals, as well as counter threats posed by predatory journals. He highlights how metrics like journal impact factor and quantity of publications also harm research integrity. Dr. Moher also discussed the importance of meta-science, the study of how research is carried out, which can help to evaluate audit and feedback systems and their effect on open science practices. CONCLUSION: Dr. Moher advocates for policy to further improve the reporting of trials and health research. The COVID-19 pandemic has exposed how a lack of open science practices and flawed systems incentivizing researchers to publish can harm research integrity. There is a need for a culture shift in assessing careers and “productivity” in academia, and this requires collaborative top-down and bottom-up approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06624-y

    CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials

    No full text
    Kenneth F Schulz, Douglas G Altman, David Moher... [Philippa Middleton... et al.] for the CONSORT Grou
    corecore